Does the Mixed Opioid Receptor Antagonist Naltrexone Mitigate Stimulant-Induced Euphoria?: A Double-Blind, Placebo Controlled Trial of Naltrexone

Spencer, ThomasBhide, PradeepZhu, JinminFaraone, StephenFitzgerald, MauraYule, AmyUchida, MaiSpencer, AndreaHall, Anna M.Koster, Ariana J.Feinberg, LeahKassabian, SarahStorch, BarbaraBiederman, Joseph2022-08-29Thomas J. Spencer, MD; Pradeep Bhide, PhD; Jinmin Zhu, PhD; Stephen V. Faraone, PhD; Maura Fitzgerald, MPH; Amy M. Yule, MD; Mai Uchida, MD; Andrea E. Spencer, MD; Anna M. Hall, BA; Ariana J. Koster, BS; Leah Feinberg, BS; Sarah Kassabian, BS ; Barbara Storch, BS; Joseph Biederman, MD. Does the Mixed Opioid Receptor Antagonist Naltrexone Mitigate Stimulant-Induced Euphoria?: A Double-Blind, Placebo Controlled Trial of Naltrexone. Journal of Clinical Psychiatry, 2017.0160-6689https://nrs.harvard.edu/URN-3:HUL.INSTREPOS:37373103en-USDoes the Mixed Opioid Receptor Antagonist Naltrexone Mitigate Stimulant-Induced Euphoria?: A Double-Blind, Placebo Controlled Trial of NaltrexoneJournal Article2017-03-1020172022-08-29